DeutschNewstral
Article
bizjournals.com on 2018-05-10 17:22
How this biotech nearly tripled its IPO price with a buyout in less than 4 months
Related news
- Here's how Redwood City biotech tripled its IPO price with a buyout in less than 4 monthsbizjournals.com
Fitbit Nearly Tripled Revenue Last Year, Files for IPOVOX recode- Peninsula biotech's $1.5 billion buyout nearly triple IPO pricebizjournals.com
- Redwood City biotech's $1.5B buyout nearly triple its 2013 IPO pricebizjournals.com
- Krystal Biotech completes IPObizjournals.com
Credit Card Bonus Offered Have Nearly TripledForbes
UBS Profit Nearly Tripled in Third QuarterThe New York Times- High Point biotech firm launches IPObizjournals.com
- MBiotech company Viventia files for IPOmarketwatch.com
- Maryland biotech NexImmune files for IPObizjournals.com
- Venture-backed Md. biotech files for IPObizjournals.com
- Another Peninsula biotech seeks big IPO paydaybizjournals.com
- Financial veteran joins pre-IPO biotech startupbizjournals.com
Biotech Startup NantHealth Targets IPO Market AgainInc.- Potential Peninsula biotech IPO lands $46 millionbizjournals.com
- Cancer-fighting Peninsula biotech targets $100M IPObizjournals.com
- Biotech raises $96M IPO during downturnbizjournals.com
- Gaithersburg biotech NexImmune files for IPObizjournals.com
Vancouver biotech firm Absci files for IPOoregonlive.com- MBiotech company Moderna files for an IPOmarketwatch.com